Interim Analysis of the Use of the Anti-Idiotype Breast Cancer Vaccine 11D10 (TriAb®) in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer

This publication has 25 references indexed in Scilit:

• Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer
  Bone Marrow Transplantation, 2000
• Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer
  Bone Marrow Transplantation, 2000
• Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer
  New England Journal of Medicine, 2000
• Posttransplant Adoptive Immunotherapy With Activated Natural Killer Cells in Patients With Metastatic Breast Cancer
  Journal of Immunotherapy, 2000
• Evidence of a Cellular Immune Response Against Sialyl-Tn in Breast and Ovarian Cancer Patients After High-Dose Chemotherapy, Stem Cell Rescue, and Immunization with Theratope STn-KLH Cancer Vaccine
  Journal of Immunotherapy, 1999
• Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation
  Blood, 1998
• High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.
  Journal of Clinical Oncology, 1997
• Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.
  Journal of Clinical Oncology, 1996
• Anti-Idiotype Antibodies as Potential Therapeutic Agents for Human Breast Cancer
  Published by Springer Nature ,1994
• B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation
  Blood, 1988